Current Events |
 |
| |
Subclinical atherosclerosis -
the presymptomatic patient at high risk for myocardial
infarction and stroke
|
| |
New York (USA), September 8-9, 2001
|
|
| |
Saturday, September 8, 2001
|
|
| |
I - The epidemiological view (high risk individuals)
|
| |
| |
Chairmen:
Antonio Gotto, Bryan Brewer
|
|
|
|
8.00 am
|
Gerd Assmann
|
PROCAM Study
|
|
|
|
Peter Wilson
|
Framingham Study
|
|
|
|
Antonio Gotto
|
AFCAPS / TexCAPS Study
|
|
|
|
Pierre Amarenco
|
Stroke Studies
|
|
|
|
|
| |
II - The biochemical / genetic view (new risk factors)
Part 1:
|
| |
| |
Chairmen:
Mario Mancini, Anders Hamsten
|
|
|
|
10.30 am
|
Michael Gimbrone
|
Endothelial markers
|
|
|
|
Paul Ridker
|
Inflammatory markers
|
|
|
|
Irwin Rosenbrg
|
Homocysteine
|
|
|
|
Anders Hamsten
|
Clotting factors
|
|
|
|
|
| |
II - The biochemical / genetic view
Part 2:
|
| |
|
|
|
| |
III - The clinical view (imaging techniques)
|
| |
| |
Chairmen:
Daniel Rader, Otmar Schober
|
|
|
|
4.00 pm
|
Daniel Rader
|
EBCT
|
|
|
|
Walter Heindel
|
Spiral CT
|
|
|
|
Otmar Schober
|
PET
|
|
|
|
Valentin Fuster
|
MRI
|
|
|
|
Steven Nissen
|
Intravascular ultrasound
|
|
|
|
|
| |
Sunday, September 9, 2001
|
|
| |
IV - The therapeutic view
|
| |
| |
Chairmen:
Wilhelm Krone, Rodolfo Paoletti
|
|
|
|
09.00 am
|
Jean Davignon
|
Statins
|
|
|
|
Jean-Charles Fruchart
|
Fibrates and PPARalpha agonists
|
|
|
|
Greg Brown
|
Nicotinic acid and its therapeutic combinations for coronary heart disease prevention
|
|
|
|
Rodolfo Paoletti
|
New approaches of statins in stroke control and prevention
|
|
|
|
| |
V - The therapeutic view and cost / benefit
|
| |
|
|
|
| |
Business meeting
|
| |
| |
|
|
|
|
1.30 pm
|
|
|
|
|
|
|
